What question did this study set out to answer?

To evaluate the diagnostic utility and sensitivity of serum glutamic pyruvic transaminase (SGP-T) relative to SGO-T in distinguishing acute hepatocellular damage from cardiac necrosis.

April 1, 1956Experimental Biology and Medicine

Serum Glutamic Pyruvic Transaminase in Cardiac and Hepatic Disease.

View Full Paper

Ask AI

Bookmark

Authors

FWFelix WröblewskiSt. Anna Hospital JLJohn S. LaDueLouisiana State University

Discussion

Member takes

Implication

Clinical evaluation reveals serum glutamic pyruvic transaminase sensitively detects acute liver damage without rising during cardiac necrosis, suggesting superior hepatic specificity over SGO-T.

Key Points

To evaluate the diagnostic utility and sensitivity of serum glutamic pyruvic transaminase (SGP-T) relative to SGO-T in distinguishing acute hepatocellular damage from cardiac necrosis.
Assessed serum glutamic pyruvic transaminase (SGP-T) alterations in the context of acute hepatic disease and cardiac necrosis.
Compared diagnostic sensitivity and organ specificity between SGP-T and serum glutamic oxaloacetic transaminase (SGO-T).
SGP-T demonstrated greater sensitivity than SGO-T for detecting acute hepatocellular damage.
SGP-T levels were not appreciably altered by acute cardiac necrosis, unlike SGO-T.

Cite This Study

Wröblewski et al. (1956) studied this question.

synapsesocial.com/papers/69e464ee892c878e25b736fc https://doi.org/10.3181/00379727-91-22330

View Full Paper

Ask AI

Bookmark

Implication

Clinical evaluation reveals serum glutamic pyruvic transaminase sensitively detects acute liver damage without rising during cardiac necrosis, suggesting superior hepatic specificity over SGO-T.

Serum Glutamic Pyruvic Transaminase in Cardiac and Hepatic Disease.

Discussion

Member takes

Implication

Key Points

Cite This Study

Serum Glutamic Pyruvic Transaminase in Cardiac and Hepatic Disease.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider